
Hereditary abnormalities of the A. fraction of human hemoglobin may be: (a) structural, in which a genetically determined change in the amino acid composition and sequence of either the alpha or the delta polypetide chains, results in the production of a hemoglobin A variant and (b) quantitative, in which changes in concentration in the hemoglobin A₂ fraction occur as a result of activation or repression of the genes for either the alpha or the delta chains or as a result of the replacement of the normal genes for either of these chains by structurally mutant genes. Because the beta and delta chains of human hemoglobins are linked, a number of conditions also involving the beta chain genes (delta-beta hybrid chain hemoglobins, hereditary persistence of fetal hemoglobin, the beta thalassemias) produce changes in hemoglobin A₂ concentration. Several non-hereditary states have been shown to produce quantitative changes in the hemoglobin A₂ fraction.
peer-reviewed
Thalassemia, Hemoglobin, Genetic disorders
Thalassemia, Hemoglobin, Genetic disorders
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
